Literature DB >> 22923812

Nuclear export signal and immunodominant CD8+ T cell epitope in influenza A virus matrix protein 1.

Masanori Terajima, Francis A Ennis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22923812      PMCID： PMC3446634          DOI： 10.1128/JVI.00894-12

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  16 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.

Authors:  A Sette; J Sidney
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

3.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors:  K C Parker; M A Bednarek; J E Coligan
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

Review 6.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Nucleocytoplasmic shuttling of receptor-interacting protein 3 (RIP3): identification of novel nuclear export and import signals in RIP3.

Authors:  Yonghui Yang; Jun Ma; Youjun Chen; Mian Wu
Journal:  J Biol Chem       Date:  2004-06-18       Impact factor: 5.157

9.  Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  G F Rimmelzwaan; A C M Boon; J T M Voeten; E G M Berkhoff; R A M Fouchier; A D M E Osterhaus
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

10.  Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.

Authors:  F Gotch; A McMichael; J Rothbard
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307
View more
  4 in total

1.  Identification of Conserved Peptides Comprising Multiple T Cell Epitopes of Matrix 1 Protein in H1N1 Influenza Virus.

Authors:  Neha Lohia; Manoj Baranwal
Journal:  Viral Immunol       Date:  2015-09-23       Impact factor: 2.257

2.  Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes.

Authors:  Carolien E van de Sandt; Mark R Pronk; Carel A van Baalen; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

3.  A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.

Authors:  Sergio M Quiñones-Parra; E Bridie Clemens; Zhongfang Wang; Hayley A Croom; Lukasz Kedzierski; Jodie McVernon; Dhanasekaran Vijaykrishna; Katherine Kedzierska
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

4.  Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.

Authors:  Yong-Dae Gwon; Sehyun Kim; Yeondong Cho; Yoonki Heo; Hansam Cho; Kihoon Park; Hee-Jung Lee; Jiwon Choi; Haryoung Poo; Young Bong Kim
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.